Bayer CropScience Expands Internal Work in microRNAs through Rosetta Green Partnership | GenomeWeb

By Doug Macron

Rosetta Green last week announced it had added a second major ag-bio company to its list of collaborators, striking a deal with Bayer CropScience to discover and characterize microRNAs that can potentially be used to improve drought tolerance and yield in cotton.

Bayer will have exclusive access to targets identified through the arrangement. In exchange, Rosetta will receive undisclosed development and commercialization milestones, as well as royalties.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.